Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL-1β and the inflammasome pathway.

Cancer Commun (Lond) · 2025 · PMC12328097 · PMID 40207651

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Although there was an increasing trend in CD8 + central memory T cells (CD8 + CD44 + CD62L + ) and CD4 + effector memory T cells (CD4 + CD44 + CD62L − ), no statistically significant difference was observed between the combination therapy and monotherapy (Figure 2G ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.